Actively Recruiting
New Perspectives in Adenomyosis Pathogenesis With Epigenetic Analysis and miRNAs
Led by Université Catholique de Louvain · Updated on 2024-04-22
50
Participants Needed
1
Research Sites
388 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Objectives: To identify differentially expressed miRNAs in the blood of adenomyosis patients in view to develop new diagnostic methods Hypotheses Circulating miRNAs may be abnormally expressed in patients suffering from adenomyosis and could be used to diagnose the disease Study Design Blood samples will be collected from healthy subjects and adenomyosis patients and miRNAs will be isolated and analyzed to detect potential differences.
CONDITIONS
Official Title
New Perspectives in Adenomyosis Pathogenesis With Epigenetic Analysis and miRNAs
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 63 18 years
- Pre-menopausal
You will not qualify if you...
- HIV or Hepatitis-positive
- Participation in another clinical study within 12 months prior to recruitment
- Presenting symptoms of endometriosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CUSL
Brussels, Woluwe-Saint-Lambert, Belgium, 1200
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here